Mechanisms of COX-2 inhibitors a possible link to CV events?

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1056卷 / 1期

关键词：

Blood Flow; Medium Release; Organ Transplant; Prostacyclin; Vessel Diameter;

D O I：

10.2165/00128415-200510560-00009

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[1] COX-2 inhibitors: increased risk of CV events?
Reactions Weekly, 2001, 867 (1) : 2 - 2
[2] Proposed risk of CV events with COX-2 inhibitors debated
Reactions Weekly, 2002, 883 (1) : 6 - 7
[3] Cardiovascular events and COX-2 inhibitors
Singh, G
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (22): : 2810 - 2811
[4] COX-2 inhibitors and risks for cardiovascular events
Kazuki Takada
Arthritis Research & Therapy, 3 (1)
[5] Cox-2 selective inhibitors induce apoptosis by both cox-2 dependent and cox-2 independent mechanisms.
Agarwal, B
Swaroop, P
Protiva, P
Chuttani, R
Ramey, WG
Holt, PR
GASTROENTEROLOGY, 2000, 118 (04) : A52 - A52
[6] Adverse drug events involving COX-2 inhibitors
Verrico, MM
Weber, RJ
McKaveney, TP
Ansani, NT
Towers, AL
ANNALS OF PHARMACOTHERAPY, 2003, 37 (09) : 1203 - 1213
[7] Risk of cardiovascular events associated with COX-2 inhibitors
不详
HOSPITAL MEDICINE, 2001, 62 (09): : 577 - 577
[8] New meta-analyses evaluate effect of COX-2 inhibitors on renal and CV events, including arrhythmia
不详
FORMULARY, 2006, 41 (11) : 558 - +
[9] COX-2 inhibitors
Brooks, PM
Day, RO
MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (08) : 433 - 436
[10] COX-2 inhibitors
Seidenberg, BC
LANCET, 1999, 353 (9168): : 1978 - 1978

← 1 2 3 4 5 →